Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
40.5%
% of WDNA's 90 holdings also in XBI
28.8%
% of XBI's 119 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.7% | 2.8% | 2.8% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 1.9% | 2.5% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 2.7% | 1.8% |
|
BRIDGEBIO PHARMA, INC. | 2.4% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XBI
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
TWIST BIOSCIENCE CORP. | 2.3% |
|
VERICEL CORPORATION | 2.1% |
 |
NOVARTIS AG | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
|
LABCORP HOLDINGS | 1.5% |
|
DUPONT DE NEMOURS INC | 1.5% |
|
TYSON FOODS INC-CL A | 1.4% |
|
JOHNSON & JOHNSON | 1.4% |
WDNA Underweight Relative to XBI
|
INSMED INC | -2.7% |
|
NEUROCRINE BIOSCIENCES INC | -2.6% |
|
INCYTE CORP | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.3% |
|
ABBVIE INC | -2.3% |
|
EXELIXIS INC | -2.1% |
|
TG THERAPEUTICS INC | -1.8% |
|
HALOZYME THERAPEUTICS INC | -1.7% |
|
BIOGEN IDEC INC | -1.6% |
|
MODERNA, INC. | -1.6% |